Cargando…
Interventional radiological therapies in colorectal hepatic metastases
Colorectal malignancy is the third most common cancer and one of the prevalent causes of death globally. Around 20-25% of patients present with metastases at the time of diagnosis, and 50-60% of patients develop metastases in due course of the disease. Liver, followed by lung and lymph nodes, are th...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10266282/ https://www.ncbi.nlm.nih.gov/pubmed/37324012 http://dx.doi.org/10.3389/fonc.2023.963966 |
_version_ | 1785058714846232576 |
---|---|
author | Vulasala, Sai Swarupa R. Sutphin, Patrick D. Kethu, Samira Onteddu, Nirmal K. Kalva, Sanjeeva P. |
author_facet | Vulasala, Sai Swarupa R. Sutphin, Patrick D. Kethu, Samira Onteddu, Nirmal K. Kalva, Sanjeeva P. |
author_sort | Vulasala, Sai Swarupa R. |
collection | PubMed |
description | Colorectal malignancy is the third most common cancer and one of the prevalent causes of death globally. Around 20-25% of patients present with metastases at the time of diagnosis, and 50-60% of patients develop metastases in due course of the disease. Liver, followed by lung and lymph nodes, are the most common sites of colorectal cancer metastases. In such patients, the 5-year survival rate is approximately 19.2%. Although surgical resection is the primary mode of managing colorectal cancer metastases, only 10-25% of patients are competent for curative therapy. Hepatic insufficiency may be the aftermath of extensive surgical hepatectomy. Hence formal assessment of future liver remnant volume (FLR) is imperative prior to surgery to prevent hepatic failure. The evolution of minimally invasive interventional radiological techniques has enhanced the treatment algorithm of patients with colorectal cancer metastases. Studies have demonstrated that these techniques may address the limitations of curative resection, such as insufficient FLR, bi-lobar disease, and patients at higher risk for surgery. This review focuses on curative and palliative role through procedures including portal vein embolization, radioembolization, and ablation. Alongside, we deliberate various studies on conventional chemoembolization and chemoembolization with irinotecan-loaded drug-eluting beads. The radioembolization with Yttrium-90 microspheres has evolved as salvage therapy in surgically unresectable and chemo-resistant metastases. |
format | Online Article Text |
id | pubmed-10266282 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-102662822023-06-15 Interventional radiological therapies in colorectal hepatic metastases Vulasala, Sai Swarupa R. Sutphin, Patrick D. Kethu, Samira Onteddu, Nirmal K. Kalva, Sanjeeva P. Front Oncol Oncology Colorectal malignancy is the third most common cancer and one of the prevalent causes of death globally. Around 20-25% of patients present with metastases at the time of diagnosis, and 50-60% of patients develop metastases in due course of the disease. Liver, followed by lung and lymph nodes, are the most common sites of colorectal cancer metastases. In such patients, the 5-year survival rate is approximately 19.2%. Although surgical resection is the primary mode of managing colorectal cancer metastases, only 10-25% of patients are competent for curative therapy. Hepatic insufficiency may be the aftermath of extensive surgical hepatectomy. Hence formal assessment of future liver remnant volume (FLR) is imperative prior to surgery to prevent hepatic failure. The evolution of minimally invasive interventional radiological techniques has enhanced the treatment algorithm of patients with colorectal cancer metastases. Studies have demonstrated that these techniques may address the limitations of curative resection, such as insufficient FLR, bi-lobar disease, and patients at higher risk for surgery. This review focuses on curative and palliative role through procedures including portal vein embolization, radioembolization, and ablation. Alongside, we deliberate various studies on conventional chemoembolization and chemoembolization with irinotecan-loaded drug-eluting beads. The radioembolization with Yttrium-90 microspheres has evolved as salvage therapy in surgically unresectable and chemo-resistant metastases. Frontiers Media S.A. 2023-05-30 /pmc/articles/PMC10266282/ /pubmed/37324012 http://dx.doi.org/10.3389/fonc.2023.963966 Text en Copyright © 2023 Vulasala, Sutphin, Kethu, Onteddu and Kalva https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Vulasala, Sai Swarupa R. Sutphin, Patrick D. Kethu, Samira Onteddu, Nirmal K. Kalva, Sanjeeva P. Interventional radiological therapies in colorectal hepatic metastases |
title | Interventional radiological therapies in colorectal hepatic metastases |
title_full | Interventional radiological therapies in colorectal hepatic metastases |
title_fullStr | Interventional radiological therapies in colorectal hepatic metastases |
title_full_unstemmed | Interventional radiological therapies in colorectal hepatic metastases |
title_short | Interventional radiological therapies in colorectal hepatic metastases |
title_sort | interventional radiological therapies in colorectal hepatic metastases |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10266282/ https://www.ncbi.nlm.nih.gov/pubmed/37324012 http://dx.doi.org/10.3389/fonc.2023.963966 |
work_keys_str_mv | AT vulasalasaiswarupar interventionalradiologicaltherapiesincolorectalhepaticmetastases AT sutphinpatrickd interventionalradiologicaltherapiesincolorectalhepaticmetastases AT kethusamira interventionalradiologicaltherapiesincolorectalhepaticmetastases AT onteddunirmalk interventionalradiologicaltherapiesincolorectalhepaticmetastases AT kalvasanjeevap interventionalradiologicaltherapiesincolorectalhepaticmetastases |